NF2 and schwannoma: Furthermore, NF2 was also shown to inhibit PI3K activity by binding to PI3K enhancer-L (PIKE-L), which disrupts binding of PIKE-L to PI3K10 and loss of NF2 in schwannoma was shown to sensitize to PI3K inhibitors.11